Diagnosis, treatment, and prevention of pulmonary embolism. Report of the WHO/International Society and Federation of Cardiology Task Force
- PMID: 1527883
Diagnosis, treatment, and prevention of pulmonary embolism. Report of the WHO/International Society and Federation of Cardiology Task Force
Abstract
To assess the state of the art of venous thrombosis and pulmonary embolism for the medical and other health-related professions, the World Health Organization (WHO) and the International Society and Federation of Cardiology (ISFC) convened a task force in Geneva, Switzerland. Members of the task force prepared position papers and presented brief oral presentations. A report was subsequently prepared by the task force members, who contributed sections in their areas of expertise. Revisions of the report occurred both during the task force meeting itself in Geneva and during the ensuing months. The final report was approved by the WHO-ISFC Task Force on Pulmonary Embolism Steering Committee. More quantitative information is needed on the frequency of venous thrombosis and pulmonary embolism in hospitalized medical patients as well as in outpatients at high risk. Population studies should focus on incidence, survival, and long-term complications in different parts of the world with respect to gender and race. Further educational efforts are needed to increase awareness about venous thrombosis and pulmonary embolism prophylaxis. Finally, research into effective techniques for changing physician practice would be useful.
Similar articles
-
Managing pulmonary embolism from presentation to extended treatment.Thromb Res. 2014 Feb;133(2):139-48. doi: 10.1016/j.thromres.2013.09.040. Epub 2013 Oct 14. Thromb Res. 2014. PMID: 24182642 Review.
-
Guidelines on diagnosis and management of acute pulmonary embolism. Task Force on Pulmonary Embolism, European Society of Cardiology.Eur Heart J. 2000 Aug;21(16):1301-36. doi: 10.1053/euhj.2000.2250. Eur Heart J. 2000. PMID: 10952823 Review. No abstract available.
-
Electronic alerts to prevent venous thromboembolism among hospitalized patients.N Engl J Med. 2005 Mar 10;352(10):969-77. doi: 10.1056/NEJMoa041533. N Engl J Med. 2005. PMID: 15758007 Clinical Trial.
-
Current status of pulmonary embolism and venous thrombosis prophylaxis.Semin Vasc Surg. 2000 Sep;13(3):171-81. Semin Vasc Surg. 2000. PMID: 11005460 Review.
-
Update in the prevention and treatment of deep vein thrombosis and pulmonary embolism.Curr Opin Anaesthesiol. 2006 Feb;19(1):52-8. doi: 10.1097/01.aco.0000192779.17151.65. Curr Opin Anaesthesiol. 2006. PMID: 16547433 Review.
Cited by
-
Medical management of venous thromboembolic disease.Ochsner J. 2000 Apr;2(2):92-101. Ochsner J. 2000. PMID: 21765670 Free PMC article.
-
Intravenous heparin dosing: patterns and variations in internists' practices.J Gen Intern Med. 1993 Oct;8(10):536-42. doi: 10.1007/BF02599634. J Gen Intern Med. 1993. PMID: 8271085 Review.
-
Anticoagulation therapy in patients with venous thromboembolic disease.J Gen Intern Med. 1998 Jun;13(6):373-8. doi: 10.1046/j.1525-1497.1998.00117.x. J Gen Intern Med. 1998. PMID: 9669566 Free PMC article.
-
Collaborative overview of randomised trials of antiplatelet therapy--III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Antiplatelet Trialists' Collaboration.BMJ. 1994 Jan 22;308(6923):235-46. BMJ. 1994. PMID: 8054013 Free PMC article.
-
A Novel Electrocardiography Model for the Diagnosis of Acute Pulmonary Embolism.Front Cardiovasc Med. 2022 Apr 11;9:825561. doi: 10.3389/fcvm.2022.825561. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35479265 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical